$33.29
0.06% today
Nasdaq, Feb 28, 09:17 pm CET
ISIN
US42222N1037
Symbol
HSTM

HealthStream, Inc. Target price 2025 - Analyst rating & recommendation

HealthStream, Inc. Classifications & Recommendation:

Buy
40%
Hold
60%

HealthStream, Inc. Price Target

Target Price $35.00
Price $33.27
Potential
Number of Estimates 2
2 Analysts have issued a price target HealthStream, Inc. 2026 . The average HealthStream, Inc. target price is $35.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 2 Analysts recommend HealthStream, Inc. to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the HealthStream, Inc. stock has an average upside potential 2026 of . Most analysts recommend the HealthStream, Inc. stock at Hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 291.65 304.35
4.51% 4.35%
EBITDA Margin 21.44% 23.46%
4.78% 9.42%

4 Analysts have issued a sales forecast HealthStream, Inc. 2025 . The average HealthStream, Inc. sales estimate is

$304m
Unlock
. This is
4.35% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$305m 4.58%
Unlock
, the lowest is
$304m 4.17%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $292m 4.51%
2025
$304m 4.35%
Unlock
2026
$320m 5.23%
Unlock

5 Analysts have issued an HealthStream, Inc. EBITDA forecast 2025. The average HealthStream, Inc. EBITDA estimate is

$71.4m
Unlock
. This is
14.19% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$72.2m 15.43%
Unlock
, the lowest is
$70.9m 13.37%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $62.5m 9.51%
2025
$71.4m 14.19%
Unlock
2026
$75.6m 5.93%
Unlock

EBITDA Margin

2024 21.44% 4.78%
2025
23.46% 9.42%
Unlock
2026
23.62% 0.68%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.66 0.66
32.00% 0.00%
P/E 50.11
EV/Sales 3.06

5 Analysts have issued a HealthStream, Inc. forecast for earnings per share. The average HealthStream, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.66
Unlock
. This is
0.00% lower
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.70 6.06%
Unlock
, the lowest is
$0.64 3.03%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.66 32.00%
2025
$0.66 0.00%
Unlock
2026
$0.69 4.55%
Unlock

P/E ratio

Current 50.79 6.14%
2025
50.11 1.34%
Unlock
2026
48.45 3.31%
Unlock

Based on analysts' sales estimates for 2025, the HealthStream, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.20 16.79%
2025
3.06 4.30%
Unlock
2026
2.91 4.98%
Unlock

P/S ratio

Current 3.47 19.25%
2025
3.32 4.17%
Unlock
2026
3.16 4.97%
Unlock

Current HealthStream, Inc. Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Canaccord Genuity Locked ➜ Locked Locked Feb 26 2025
JMP Securities Locked ➜ Locked Locked Feb 06 2025
Barclays Locked ➜ Locked Locked Oct 23 2024
Canaccord Genuity Locked ➜ Locked Locked Oct 23 2024
Analyst Rating Date
Locked
Canaccord Genuity: Locked ➜ Locked
Feb 26 2025
Locked
JMP Securities: Locked ➜ Locked
Feb 06 2025
Locked
Barclays: Locked ➜ Locked
Oct 23 2024
Locked
Canaccord Genuity: Locked ➜ Locked
Oct 23 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today